-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on AbbVie, Raises Price Target to $335

Benzinga·11/16/2026 15:00:37
Listen to the news
Barclays analyst Emily Field maintains AbbVie (NYSE:ABBV) with a Overweight and raises the price target from $325 to $335.